We noticed a decreasing trend in the access to reperfusion therapies (73% vs. 66.6%); the fibrinolysis was the most commonly used therapy.
← all excerpts
[Impact of the COVID-19 pandemic on ST- elevation myocardial infarction care in Peru].
1
—
—
We noticed a decreasing trend in the access to reperfusion therapies (73% vs. 66.6%); the fibrinolysis was the most commonly used therapy.